Avalo Therapeutics Files Prospectus For Offering Up To 128,189 Common Shares On Behalf Of Selling Shareholders

Benzinga Newsdesk www.benzinga.com Neutral 92.9%

Neg 0% Neu 92.9% Pos 0%

https://www.sec.gov/Archives/edgar/data/1534120/000110465926087573/tm2620167-5_424b3.htm

Comments

No comments yet. Be the first!